Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $0.7401
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Nov 17, 25 | HC Wainwright & Co. |
| maintain |
| Buy |
| Buy |
| Mar 21, 25 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 13, 25 | HC Wainwright & Co. | maintain | Buy | Buy |
| Nov 19, 24 | HC Wainwright & Co. | maintain | Buy | Buy |
| Nov 8, 24 | HC Wainwright & Co. | maintain | Buy | Buy |
| Oct 1, 24 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 26, 24 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 13, 24 | Alliance Global Partners | maintain | Buy | Buy |
| Aug 12, 24 | HC Wainwright & Co. | maintain | Buy | Buy |
1230 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-09-18
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 60.25 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 54.38 | Oscillator | Neutral |
| Williams %R (14) | -45.62 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.03 (Hist -0.00) | Oscillator | Sell |
| Average Directional Index (14) | 26.85 (+DI 24.6 / -DI 13.9) | Trend | Strong Buy |
| EMA 20 | 0.71 | MA | Strong Buy |
| SMA 20 | 0.72 | MA | Buy |
| EMA 50 | 0.68 | MA | Strong Buy |
| SMA 50 | 0.65 | MA | Strong Buy |
| SMA 200 | 0.66 | MA | Strong Buy |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 15-12G | Sep 21, 2026 | 2026-09-21 16:15:21 | View |
| EFFECT | Sep 14, 2026 | 2026-09-15 00:15:03 | View |
| SC 13G/A | Sep 11, 2026 | 2026-09-11 11:47:02 | View |
| 4/A | Sep 11, 2026 | 2026-09-11 11:00:41 | View |
| 25 | Sep 9, 2026 | 2026-09-09 16:55:40 | View |
| 4 | Sep 9, 2026 | 2026-09-09 16:21:03 | View |
| 4 | Sep 9, 2026 | 2026-09-09 16:20:33 | View |
| 4 | Sep 9, 2026 | 2026-09-09 16:20:06 | View |
| 4 | Sep 9, 2026 | 2026-09-09 16:19:38 | View |
| 4 | Sep 9, 2026 | 2026-09-09 16:19:07 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
Here is how Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) and Agilent Technologies (A) have performed compared to their sector so far this year.
Scheme Exchange Ratio determined at 0.111 pursuant to the terms of the merger agreement Scheme of arrangement expected to become effective on September 3, 2026, with Barinthus Bio ADSs expected to cease trading on Nasdaq prior to market open Topco common stock expected to commence trading on Nasdaq under the ticker symbol “CLYD” following completion of the proposed combination with Clywedog GERMANTOWN, Md., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio,” or the “Company”), today provided an update regarding the anticipated closing of its proposed combination with Clywedog Therapeutics, Inc. (“Clywedog”) in an all-stock transaction.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -0.28 | -0.26 | Beat 7.1% | — |
| Apr 30, 2026 | -0.36 | -0.14 | Beat 61.1% | — |
| Mar 13, 2026 | -0.40 | -0.27 | Beat 32.5% | — |
| Nov 7, 2025 | -0.45 | -0.36 | Beat 20.0% | — |
| Aug 7, 2025 | -0.29 | -0.52 | Miss -79.3% | — |
| May 7, 2025 | -0.34 | -0.49 | Miss -44.1% | — |
TTM vs. 5-year historical average (annual ratios)
| Metric | BRNS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.7x | 1.1x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -0.7x | EPS est. -1.07 | In line |
| Price / Book | 0.5x | 0.7x | Discount |
| Price / Sales | — | 344.7x | Discount |
| EV / EBITDA | 0.5x | -4.4x | Discount |
| Return on equity | -59.2% | — | Weak |
| Gross margin | 0.0% | 80.0% | Below hist. |
| Debt / Equity | 0.18 | 0.08 | Conservative |
| Piotroski / Altman Z | 1/9 | Z -5.68 | Distress |
Discounted cash flow model
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 9, 26 | Oxford Science Enterprises Plc | other: former 10% owner | U-Tender | 8,797,770 @ $0.111 | $976.6K |
| Sep 9, 26 | Wright Robin | director | D-Return | 18,604 @ $4.27 | $79.44K |
| Sep 9, 26 | Wright Robin | director | D-Return | 19,197 @ $2.27 | $43.58K |
| Sep 9, 26 | Wright Robin | director | D-Return | 19,516 @ $2.34 | $45.67K |
| Sep 9, 26 | Wright Robin | director | D-Return | 20,174 @ $1.00 | $20.17K |
| Sep 9, 26 | Wright Robin | director | D-Return | 48,256 @ $0.0001 | $5 |
| Sep 9, 26 | Wright Robin | director | D-Return | 20,394 @ $0.0001 | $2 |
| Sep 9, 26 | Wright Robin | director | D-Return | 34,328 @ $17.00 | $583.6K |
FY2024 · 10-K disclosure